CanSino Biologics Inc Class H 06185
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HKD 21.35
- Day Range
- HKD 21.10–22.30
- 52-Week Range
- HKD 14.80–34.70
- Bid/Ask
- HKD 21.40 / HKD 21.50
- Market Cap
- HKD 5.32 Bil
- Volume/Avg
- 1.5 Mil / 1.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 11.08
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. Its products are Menhycia and Menphecia; Convidecia, Convidecia Air, and XBB.1.5 Variant; Ad5-EBOV; PCV13i; PBPV; and DTcP Infant. Its geographic areas are PRC and Overseas. It generates the majority of its revenue from the PRC.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 1,494
- Website
- https://www.cansinotech.com
Comparables
Valuation
Metric
|
06185
|
300142
|
06660
|
---|---|---|---|
Price/Earnings (Normalized) | — | 43.84 | 32.63 |
Price/Book Value | 0.95 | 2.47 | 2.42 |
Price/Sales | 11.08 | 5.93 | 7.40 |
Price/Cash Flow | — | 26.89 | — |
Price/Earnings
06185
300142
06660
Financial Strength
Metric
|
06185
|
300142
|
06660
|
---|---|---|---|
Quick Ratio | 2.20 | 2.46 | 0.74 |
Current Ratio | 2.39 | 2.85 | 0.95 |
Interest Coverage | −28.32 | 47.19 | −51.05 |
Quick Ratio
06185
300142
06660
Profitability
Metric
|
06185
|
300142
|
06660
|
---|---|---|---|
Return on Assets (Normalized) | −20.95% | 3.37% | −3.57% |
Return on Equity (Normalized) | −35.51% | 5.57% | −6.57% |
Return on Invested Capital (Normalized) | −25.25% | 3.91% | −4.09% |
Return on Assets
06185
300142
06660
Drug Manufacturers - Specialty & Generic Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Vzdxmygyq | Kgvldp | $79.9 Bil | |
ZTS
| Zoetis Inc Class A | Bvqzddlt | Ylst | $79.3 Bil | |
HLN
| Haleon PLC ADR | Tqlknghwp | Zbbm | $38.1 Bil | |
VTRS
| Viatris Inc | Jxjwxhnl | Tlvhy | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Qyjncfzr | Cyw | $11.7 Bil | |
CTLT
| Catalent Inc | Kwmfpbqpg | Fthdfdy | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Byhspfgb | Zzvcf | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Dvmvkwsl | Qvzg | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Fgyfpll | Zwscmmx | $3.2 Bil | |
GTBIF
| Green Thumb Industries Inc | Fxxwllvvg | Xqjz | $3.1 Bil |